Boehringer Ingelheim to present highly anticipated data from landmark TIOSPIR ™ trial, and their respiratory pipeline products in COPD, asthma, IPF and lung cancer at ERS 2013
Boehringer Ingelheim to present highly anticipated data from landmark TIOSPIR ™ trial, and their respiratory pipeline products in COPD, asthma, IPF and lung cancer at ERS 2013
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Asthma | Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | Lung Cancer | Research | Respiratory Medicine